These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 33824303)
1. LncRNA MALAT1 promotes gastric cancer progression via inhibiting autophagic flux and inducing fibroblast activation. Wang Z; Wang X; Zhang T; Su L; Liu B; Zhu Z; Li C Cell Death Dis; 2021 Apr; 12(4):368. PubMed ID: 33824303 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-183 affects the development of gastric cancer by regulating autophagy via MALAT1-miR-183-SIRT1 axis and PI3K/AKT/mTOR signals. Li H; He C; Wang X; Wang H; Nan G; Fang L Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3163-3171. PubMed ID: 31352788 [TBL] [Abstract][Full Text] [Related]
3. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy. Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543 [TBL] [Abstract][Full Text] [Related]
4. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer. Zhang YF; Li CS; Zhou Y; Lu XH Life Sci; 2020 Mar; 244():117280. PubMed ID: 31926239 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer. YiRen H; YingCong Y; Sunwu Y; Keqin L; Xiaochun T; Senrui C; Ende C; XiZhou L; Yanfan C Mol Cancer; 2017 Nov; 16(1):174. PubMed ID: 29162158 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression. Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846 [TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA MALAT1 Promotes Aggressive Pancreatic Cancer Proliferation and Metastasis via the Stimulation of Autophagy. Li L; Chen H; Gao Y; Wang YW; Zhang GQ; Pan SH; Ji L; Kong R; Wang G; Jia YH; Bai XW; Sun B Mol Cancer Ther; 2016 Sep; 15(9):2232-43. PubMed ID: 27371730 [TBL] [Abstract][Full Text] [Related]
8. Long non‑coding RNA JPX promotes gastric cancer progression by regulating CXCR6 and autophagy via inhibiting miR‑197. Han X; Liu Z Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33215222 [TBL] [Abstract][Full Text] [Related]
9. LncRNA MALAT1 potentiates autophagy‑associated cisplatin resistance by regulating the microRNA‑30b/autophagy‑related gene 5 axis in gastric cancer. Xi Z; Si J; Nan J Int J Oncol; 2019 Jan; 54(1):239-248. PubMed ID: 30365113 [TBL] [Abstract][Full Text] [Related]
10. CCL21 activation of the MALAT1/SRSF1/mTOR axis underpins the development of gastric carcinoma. Fu Q; Tan X; Tang H; Liu J J Transl Med; 2021 May; 19(1):210. PubMed ID: 34001131 [TBL] [Abstract][Full Text] [Related]
11. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway. Gu Y; Fei Z; Zhu R Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198 [TBL] [Abstract][Full Text] [Related]
12. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression. Li X; Na H; Xu L; Zhang X; Feng Z; Zhou X; Cui J; Zhang J; Lin F; Yang S; Yue F; Mousa H; Zuo Y Biomed Pharmacother; 2020 Jan; 121():109644. PubMed ID: 31766099 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA MALAT1 enhances the apoptosis of cardiomyocytes through autophagy inhibition by regulating TSC2-mTOR signaling. Hu H; Wu J; Yu X; Zhou J; Yu H; Ma L Biol Res; 2019 Nov; 52(1):58. PubMed ID: 31783925 [TBL] [Abstract][Full Text] [Related]
14. SP1-activated long noncoding RNA lncRNA GCMA functions as a competing endogenous RNA to promote tumor metastasis by sponging miR-124 and miR-34a in gastric cancer. Tian Y; Ma R; Sun Y; Liu H; Zhang H; Sun Y; Liu L; Li Y; Song L; Gao P Oncogene; 2020 Jun; 39(25):4854-4868. PubMed ID: 32439864 [TBL] [Abstract][Full Text] [Related]
15. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway. Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138 [TBL] [Abstract][Full Text] [Related]
16. LncRNA-LOC101928316 contributes to gastric cancer progression through regulating PI3K-Akt-mTOR signaling pathway. Li C; Liang G; Yang S; Sui J; Wu W; Xu S; Ye Y; Shen B; Zhang X; Zhang Y Cancer Med; 2019 Aug; 8(9):4428-4440. PubMed ID: 31207155 [TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNA MALAT1 Regulates Cancer Glucose Metabolism by Enhancing mTOR-Mediated Translation of TCF7L2. Malakar P; Stein I; Saragovi A; Winkler R; Stern-Ginossar N; Berger M; Pikarsky E; Karni R Cancer Res; 2019 May; 79(10):2480-2493. PubMed ID: 30914432 [TBL] [Abstract][Full Text] [Related]
18. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway. Huang YK; Kang WM; Ma ZQ; Liu YQ; Zhou L; Yu JC Carcinogenesis; 2019 Apr; 40(2):370-379. PubMed ID: 30371738 [TBL] [Abstract][Full Text] [Related]
19. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling. Tang Y; Xiao G; Chen Y; Deng Y Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897 [TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanism of the Canonical Oncogenic lncRNA MALAT1 in Gastric Cancer. Xu W; Ding M; Wang B; Cai Y; Guo C; Yuan C Curr Med Chem; 2021; 28(42):8800-8809. PubMed ID: 34036905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]